Samsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)

Posted on by

Samsung Ventures makes investment in preclinical-stage biopharmaceutical company BrickBio Proceeds will be used to support further development and advancement of BrickBio’s protein engineering technology and preclinical assets INCHEON, Korea and WALTHAM, Mass., March 18, 2024 /PRNewswire/…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.